Pheon Therapeutics Inc

Oxigen USA Inc, based in Cambridge, MA, specializes in providing fast and convenient online mobile top-up services to customers worldwide, allowing users to recharge mobile phones for themselves or for loved ones in over 100 countries. With partnerships across more than 220 mobile operators, the company aims to offer the best value and flexibility without the obligations of traditional plans. The platform emphasizes user-friendly navigation, secure payment processes, and a 100% money-back guarantee for unfulfilled transactions. Customers enjoy the convenience of purchasing airtime and data at any time, benefiting from instant top-ups and competitive pricing in a safe online environment. Generated from the website

Nerviano Medical Sciences Srl (NMS) is a biotechnology company specializing in the discovery and clinical development of New Chemical Entities (NCEs) for oncology, including Small Molecules and Antibody-Drug Conjugates (ADCs). The company is committed to delivering innovative cancer treatments by focusing on novel drug targets and mechanisms of action to provide first and best-in-class personalized therapies. With a strong emphasis on scientific expertise, NMS leverages its capabilities in Small Molecules and ADCs to advance novel therapeutic solutions from discovery through clinical development. Their proven track record highlights their dedication to developing effective oncology drugs that bring hope to patients in need. Generated from the website

CRIO Inc., based in Cambridge, MA, provides an intuitive eSource solution designed to enhance clinical trial efficiency by collecting data directly at the point of patient interaction. By streamlining workflows and ensuring protocol compliance, CRIO enables better site performance and faster decision-making for sponsors, CROs, and research sites alike. With a focus on quality and reliability, CRIO offers configurable and scalable templates, real-time data access, and robust reporting capabilities to support the diverse needs of clinical trial stakeholders. The platform not only increases enrollment and accelerates startup times but also significantly reduces protocol deviations, making it a vital tool for advancing clinical research. Generated from the website